<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0039">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Müller</surname>
    <given-names>RH</given-names>
   </string-name>, 
   <string-name>
    <surname>Jacobs</surname>
    <given-names>C</given-names>
   </string-name>, 
   <string-name>
    <surname>Kayser</surname>
    <given-names>O.</given-names>
   </string-name>
  </person-group> (
  <year>2001</year>). 
  <article-title>Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future</article-title>. 
  <source>Adv Drug Deliv Rev</source>
  <volume>47</volume>:
  <fpage>3</fpage>–
  <lpage>19</lpage>. 200.
  <pub-id pub-id-type="pmid">11251242</pub-id>
 </mixed-citation>
</ref>
